1. Home
  2. ICD-10-PCS Index
  3. Administration
  4. Physiological Systems and Anatomical Regions
  5. Introduction
  6. 3E033GR
  • Version 2026
  • Billable Code

2026 ICD-10-PCS Procedure Code 3E033GR

Introduction of Other Therapeutic Monoclonal Antibody into Peripheral Vein, Percutaneous Approach

ICD-10-PCS Code:
3E033GR
ICD-10-PCS Code for:
Introduce Oth Rx Moncln Ab in Periph Vein, Perc
Is Billable?
Yes - Valid for Submission
Code Navigator:

3E033GR is a billable procedure code used to specify the performance of introduction of other therapeutic monoclonal antibody into peripheral vein, percutaneous approach. The code is valid for the year 2026 for the submission of HIPAA-covered transactions. The procedure code involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

3E033GR PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is peripheral vein.

Position Designation Character Label Procedures Notes
1 Section 3 Administration
2 Body System E Physiological Systems and Anatomical Regions
3 Operation 0 Introduction

Involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
4 BodySystem/Region 3 Peripheral Vein  
5 Approach 3 Percutaneous

Involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
6 Substance G Other Therapeutic Substance Includes:
  • Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
  • Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent
7 Qualifier R Other Therapeutic Monoclonal Antibody

Replacement Code

3E033GR replaces the following previously assigned ICD-10-PCS code(s):

  • XW033A3 - Introduce Bezlotoxumab in Periph Vein, Perc, New Tech 3
  • XW033A3 - Introduce Bezlotoxumab in Periph Vein, Perc, New Tech 3
  • XW033A3 - Introduce Bezlotoxumab in Periph Vein, Perc, New Tech 3

Replaced Code

3E033GR was replaced in the 2026 ICD-10-PCS code set with the code(s):

  • XW033MA - Introduce Emapalumab-lzsg in Periph Vein, Perc, New Tech 10

Other ICD-10-PCS Codes Used for Introduction Peripheral Vein


  • 3E03002 Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach

  • 3E03003 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach

  • 3E03005 Introduction of Other Antineoplastic into Peripheral Vein, Open Approach

  • 3E0300M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach

  • 3E0300P Introduction of Clofarabine into Peripheral Vein, Open Approach

  • 3E03016 Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open

  • 3E03017 Introduction of Other Thrombolytic into Peripheral Vein, Open Approach

  • 3E03028 Introduction of Oxazolidinones into Peripheral Vein, Open Approach

  • 3E03029 Introduction of Other Anti-infective into Peripheral Vein, Open Approach

  • 3E0303Z Introduction of Anti-inflammatory into Peripheral Vein, Open Approach

  • 3E0304Z Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach

  • 3E0306Z Introduction of Nutritional Substance into Peripheral Vein, Open Approach

  • 3E0307Z Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach

  • 3E030FZ Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach

  • 3E030GC Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach

  • 3E030GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach

  • 3E030HZ Introduction of Radioactive Substance into Peripheral Vein, Open Approach

  • 3E030KZ Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach

  • 3E030NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach

  • 3E030PZ Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach

  • 3E030RZ Introduction of Antiarrhythmic into Peripheral Vein, Open Approach

  • 3E030TZ Introduction of Destructive Agent into Peripheral Vein, Open Approach

  • 3E030U0 Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

  • 3E030U1 Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

  • 3E030VG Introduction of Insulin into Peripheral Vein, Open Approach

  • 3E030VH Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach

  • 3E030VJ Introduction of Other Hormone into Peripheral Vein, Open Approach

  • 3E030WK Introduction of Immunostimulator into Peripheral Vein, Open

  • 3E030WL Introduction of Immunosuppressive into Peripheral Vein, Open

  • 3E030XZ Introduction of Vasopressor into Peripheral Vein, Open Approach

  • 3E03302 Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

  • 3E03303 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

  • 3E03305 Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach

  • 3E0330M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach

  • 3E0330P Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach

  • 3E03316 Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous

  • 3E03317 Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach

  • 3E03328 Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach

  • 3E03329 Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach

  • 3E0333Z Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach

  • 3E0334Z Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach

  • 3E0336Z Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach

  • 3E0337Z Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach

  • 3E033FZ Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach

  • 3E033GC Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach

  • 3E033GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach

  • 3E033GQ Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach

  • 3E033HZ Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach

  • 3E033KZ Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach

  • 3E033NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach

  • 3E033PZ Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach

  • 3E033RZ Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach

  • 3E033TZ Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach

  • 3E033U0 Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

  • 3E033U1 Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

  • 3E033VG Introduction of Insulin into Peripheral Vein, Percutaneous Approach

  • 3E033VH Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach

  • 3E033VJ Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach

  • 3E033WK Introduction of Immunostimulator into Peripheral Vein, Percutaneous

  • 3E033WL Introduction of Immunosuppressive into Peripheral Vein, Percutaneous

  • 3E033XZ Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2026 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2025 through September 30, 2026.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.